Literature DB >> 15905133

Leishmania infantum amastigotes resistant to nitric oxide cytotoxicity: Impact on in vitro parasite developmental cycle and metabolic enzyme activities.

Philippe Holzmuller1, Mallorie Hide, Denis Sereno, Jean-Loup Lemesre.   

Abstract

Nitric oxide (NO) has been demonstrated to be the principal effector molecule mediating intracellular killing of Leishmania. The free radical characteristic of NO prevented direct induction of resistance in Leishmania wild-type parasites. Starting from the previous observation that antimony-resistant amastigotes of Leishmania infantum were not affected by NO-induced apoptotic death, we used a continuous NO pressure protocol and succeeded in inducing NO resistance in amastigote forms of L. infantum. Two clones resistant to 50 microM (LiNOR50) and 100 microM (LiNOR100) of the NO donor DETA/NONOate, derived from parental clone weakly resistant to trivalent antimony (LiSbIIIR4), were selected and analysed. Both clones were also resistant to other NO donors, particularly SNAP. In the absence of potassium antimonyl tartrate, all clones (LiSbIIIR4, LiNOR50 and LiNOR100) lost their antimony resistance almost totally. Interestingly, the parasitic developmental life cycle of NO-resistant mutants was dramatically disturbed. NO-resistant amastigotes differentiated more rapidly into promastigotes than the wild-type ones. Nevertheless, NO-resistant amastigotes produce a maximal number of parasites 1.5-2 times lower than the wild-type whereas, after differentiation, NO-resistant promastigotes produced more cells than the wild-type. We showed that this last phenomenon could be a consequence of the overexpression of parasitic enzymes involved in both glycolysis and respiration processes. NO-resistant amastigotes overexpressed three enzymes: cis-aconitase, glyceraldehyde-3-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. The two first enzymes are NO molecular targets which could be directly involved in NO resistance and the third one could interfere in modifying Leishmania metabolism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15905133     DOI: 10.1016/j.meegid.2005.03.003

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  13 in total

1.  Fatty acid profiles in Leishmania spp. isolates with natural resistance to nitric oxide and trivalent antimony.

Authors:  Alana Freire de Azevedo; Jorge Luís de Lisboa Dutra; Micheli Luize Barbosa Santos; Darlisson de Alexandria Santos; Péricles Barreto Alves; Tatiana Rodrigues de Moura; Roque Pacheco de Almeida; Marcelo Ferreira Fernandes; Ricardo Scher; Roberta Pereira Miranda Fernandes
Journal:  Parasitol Res       Date:  2013-10-06       Impact factor: 2.289

2.  Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death.

Authors:  Despina Smirlis; Michael Duszenko; Antonio Jiménez Ruiz; Effie Scoulica; Patrick Bastien; Nicolas Fasel; Ketty Soteriadou
Journal:  Parasit Vectors       Date:  2010-11-17       Impact factor: 3.876

3.  Studies in the mouse model identify strain variability as a major determinant of disease outcome in Leishmania infantum infection.

Authors:  Filipe Marques; Sílvia Vale-Costa; Tânia Cruz; Joana Moreira Marques; Tânia Silva; João Vilares Neves; Sofia Cortes; Ana Fernandes; Eduardo Rocha; Rui Appelberg; Pedro Rodrigues; Ana M Tomás; Maria Salomé Gomes
Journal:  Parasit Vectors       Date:  2015-12-18       Impact factor: 3.876

4.  Immunopathological Features of Canine Myocarditis Associated with Leishmania infantum Infection.

Authors:  Alessandro Costagliola; Giuseppe Piegari; Iwona Otrocka-Domagala; Davide Ciccarelli; Valentina Iovane; Gaetano Oliva; Valeria Russo; Laura Rinaldi; Serenella Papparella; Orlando Paciello
Journal:  Biomed Res Int       Date:  2016-06-19       Impact factor: 3.411

5.  Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria.

Authors:  Naouel Eddaikra; Khatima Ait-Oudhia; Ihcen Kherrachi; Bruno Oury; Farida Moulti-Mati; Razika Benikhlef; Zoubir Harrat; Denis Sereno
Journal:  PLoS Negl Trop Dis       Date:  2018-03-21

6.  Arginase expression modulates nitric oxide production in Leishmania (Leishmania) amazonensis.

Authors:  Stephanie Maia Acuña; Juliana Ide Aoki; Maria Fernanda Laranjeira-Silva; Ricardo Andrade Zampieri; Juliane Cristina Ribeiro Fernandes; Sandra Marcia Muxel; Lucile Maria Floeter-Winter
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

7.  Cytokine Effect of TLR3, TLR4, and TLR7 Agonists Alone or Associated with Leishmania infantum Antigen on Blood from Dogs.

Authors:  Pamela Martínez-Orellana; Sara Montserrat-Sangrà; Paulina Quirola-Amores; Noemí González; Laia Solano-Gallego
Journal:  Biomed Res Int       Date:  2018-11-12       Impact factor: 3.411

8.  In vivo transcriptional profiling of Listeria monocytogenes and mutagenesis identify new virulence factors involved in infection.

Authors:  Ana Camejo; Carmen Buchrieser; Elisabeth Couvé; Filipe Carvalho; Olga Reis; Pierre Ferreira; Sandra Sousa; Pascale Cossart; Didier Cabanes
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

9.  The Multiple Forms of Leishmania major in BALB/C Mice Lung in Iran.

Authors:  Sh Shirbazou; M Jafari
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

10.  Proteomic identification of S-nitrosylated proteins in the parasite Entamoeba histolytica by resin-assisted capture: insights into the regulation of the Gal/GalNAc lectin by nitric oxide.

Authors:  Rivka Hertz; Shani Ben Lulu; Preeti Shahi; Meirav Trebicz-Geffen; Moran Benhar; Serge Ankri
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.